phosphoric acid, trisodium salt has been researched along with Aortic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Fukumoto, S; Hirohama, D; Jimbo, R; Kawakami-Mori, F; Majtan, B; Mu, S; Shimizu, Y; Shimosawa, T; Yatomi, Y | 1 |
| Kuro-o, M; Moe, OW | 1 |
2 other study(ies) available for phosphoric acid, trisodium salt and Aortic Diseases
| Article | Year |
|---|---|
Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
Topics: Animals; Aorta; Aortic Diseases; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factors; Glucuronidase; Klotho Proteins; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteoblasts; Phosphates; Phosphorylation; Protein Kinase Inhibitors; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 1; Recombinant Proteins; Renal Insufficiency, Chronic; Signal Transduction; Transfection; Vascular Calcification | 2014 |
Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent?
Topics: Animals; Aortic Diseases; Fibroblast Growth Factors; Glucuronidase; Klotho Proteins; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphates; Vascular Calcification | 2014 |